NHLBI folic acid supplementation trial on cardiovascular disease suggested by researchers.
This article was originally published in The Tan Sheet
Executive Summary
NHLBI FOLIC ACID CLINICAL TRIALS ON CVD RISK REDUCTION were recommended by Arno Motulsky, MD, University of Washington, at an NHLBI advisory council meeting Feb. 15. The National Heart, Lung, and Blood Institute should support clinical studies to assess whether folic acid supplements can reduce the risk of cardiovascular disease associated with increased homocysteine levels, Motulsky suggested.